Broadbill Pharma India Private Limited

Pharma company that trades, manufactures, and sells various pharmaceutical and healthcare products.

2015 | Ghaziabad, Uttar Pradesh (India) | Inactive
Last Updated: February 06, 2025

Broadbill Pharma India Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 6 Days
  • Last Filing with ROC 31 Mar 2018
  • Revenue Growth %
  • Profit Growth -709.06%
  • Ebitda -250.72%
  • Net Worth -75.11%
  • Total Assets -31.14%

About Broadbill Pharma India

Broadbill Pharma India Private Limited (BPIPL) is Strike Off company established on 18 Feb 2015 with its office registered at Ghaziabad, Uttar Pradesh, India and has been running since 10 Year, 6 Days with a paid up capital of 0.10 M. According to MCA records, 2 Directors are linked to this company as of 06 Feb 2025.

Company Details

  • Location

    Ghaziabad, Uttar Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24233UP2015PTC068999

  • Company No.

    068999

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    18 Feb 2015

  • Date of AGM

    29 Sep 2018

  • Date of Balance Sheet

    31 Mar 2018

  • Listing Status

    Unlisted

  • ROC Code

    Roc Kanpur

Industry

Pharma

Who are the key members and board of directors at Broadbill Pharma India?

Board Members (2)

NameDesignationAppointment DateStatus
Hema Tyagi Country flag representing In Director 18-Feb-2015Current
Vandana Bhilare Country flag representing In Additional Director 30-Jun-2017Current

Financial Performance of Broadbill Pharma India.

Broadbill Pharma India Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 709.06% decrease in profit. The company's net worth observed a substantial decline by a decrease of 75.11%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-31.14%
Profit or Loss
-709.06%
Net Worth
-75.11%
EBITDA
-250.72%

What is the Ownership and Shareholding Structure of Broadbill Pharma India?

In 2018, Broadbill Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Broadbill Pharma India?

Unlock and access historical data on people associated with Broadbill Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Broadbill Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Broadbill Pharma India's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Broadbill Pharma India

Recent activity within the organization

  • Annual General Meeting

    Broadbill Pharma India Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records.

    29 Sep 2018

  • Balance Sheet

    Broadbill Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Kanpur.

    31 Mar 2018

  • Director Appointment

    Vandana Umesh Bhilare was appointed as a Additional Director was appointed as a Additional Director on 30 Jun 2017 & has been associated with this company since 7 years 7 months .

    30 Jun 2017

  • Director Appointment

    Hema Tyagi was appointed as a Director was appointed as a Director on 18 Feb 2015 & has been associated with this company since 10 years 6 days .

    18 Feb 2015

  • Company Incorporation

    Broadbill Pharma India Private Limited was registered on 18 Feb 2015 with Roc Kanpur & aged 10 years 6 days as per MCA records.

    18 Feb 2015

Frequently asked questions

  • Broadbill Pharma India Private Limited was incorporated on 18 Feb 2015.

  • The authorized share capital of Broadbill Pharma India Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Broadbill Pharma India Private Limited.

    • Hema Tyagi
    • Vandana Umesh Bhilare
  • As per Ministry of Corporate Affairs (Mca), the registered address of Broadbill Pharma India Private Limited is House No.791 New Arya Nagar Opposite Ram Krishan Institute, Delhi-Me Erut Road India, Ghaziabad, Uttar Pradesh, 201001.

  • The corporate identification number (CIN) of Broadbill Pharma India Private Limited is U24233UP2015PTC068999 and the company number is 068999 as per Ministry of Corporate Affairs (MCA).

  • The financial reports for the fiscal year 2018 indicates that The net worth of Broadbill Pharma India Private Limited has experienced an downturn of -75.11%.

  • The most recent Balance Sheet for Broadbill Pharma India Private Limited was filed with the ROC on 31 Mar 2018.

People also Viewed

Similar Companies Based on Pharmaceutical Retailers & Distributors